louisakewell, Author at European Medical Journal - Page 48 of 153

Continue
EMJ
8th December 2016

New Horizons in ASV

Prof Simonds comments on the results of the SERVE-HF trial and also discusses the different uses of ASV as therapy for complex sleep apnoea, central…
EMJ
8th December 2016

Adaptive Servo Ventilation – What’s next? by Anita K. Simonds

We bring you a recording of a discussion by a panel of experts entitled New Horizons in ASV: Advancing science | informing ASV clinical practice. ASV has…
3 Mins
8th December 2016

Patients Wait Four Months Before Seeking Cancer Diagnosis

Lugano-Singapore, December 7, 2016 – Patients wait an average of four months before seeking a cancer diagnosis, researchers report at the ESMO Asia 2016…
4 Mins
8th December 2016

Supportive Care for Cancer Patients Remains Inadequate

Pain relief and other forms of supportive care for cancer patients are insufficient, researchers report at the ESMO ASIA 2016 Congress.
4 Mins
8th December 2016

Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS

Germany, December 07, 2016 – Neurimmune and TVM Capital Life Science’s latest fund, TVM Life Science Ventures VII, today announced their investment in…
2 Mins
1st December 2016

Introducing EMJ Gastroenterology 5.1

United Kingdom, December 1, 2016: Our penultimate eJournal is here: this year’s EMJ Gastroenterology is full of material for those with a passion for all…
8 Mins
1st December 2016

Review of the 24th United European Gastroenterology Week 2016

This occasion marked the fourth time the beautiful city of Vienna has played host to UEG Week, facilitating the gathering of leading scientists…
2 Mins
1st December 2016

Experience of the Management of Decompensated Hepatitis C Virus in Cirrhotic Patients with Low-Dose Sofosbuvir and Ribavirin Combined with Daclatasvir

The limited treatment varieties for patients with decompensated cirrhosis due to the hepatitis C virus (HCV) remain a challenge. Read more
6 Mins
1st December 2016

Preventing Collateral Damage in the Inflammatory Bowel Disease Patient: Using Disease Assessment and Prognostic Factors to Optimise Clinical Outcomes

Inflammatory bowel diseases (IBDs) are chronic disabling conditions. Despite the benefits of anti-tumour necrosis factor-α agents in improving quality…
2 Mins
1st December 2016

Associations of the TLR2 and TLR4 Alleles with Hepatitis C Virus Infection Within an Egyptian Population: A Multicentre Family-Based Study

The human toll-like receptor (TLR) family consists of 10 receptors that are critically important within innate immunity. TLRs recognise and respond to…